Blueray Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 24-06-2024
- Paid Up Capital ₹ 0.10 M
as on 24-06-2024
- Company Age 9 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.66 Cr
as on 24-06-2024
- Revenue 15931.84%
(FY 2022)
- Profit 113.85%
(FY 2022)
- Ebitda 80.32%
(FY 2022)
- Net Worth 13.71%
(FY 2022)
- Total Assets 37.13%
(FY 2022)
About Blueray Lifesciences
The Corporate was formerly known as Galaxy Mintrade Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.66 Cr.
Debajyoti Kumar and Panchanan Misra serve as directors at the Company.
- CIN/LLPIN
U51909WB2015PTC205468
- Company No.
205468
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Mar 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Blueray Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Debajyoti Kumar  | Additional Director | 09-Jul-2018 | Current |
| Panchanan Misra | Director | 12-Dec-2016 | Current |
Financial Performance of Blueray Lifesciences.
Blueray Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15931.84% increase. The company also saw a substantial improvement in profitability, with a 113.85% increase in profit. The company's net worth Soared by an impressive increase of 13.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blueray Lifesciences?
In 2021, Blueray Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Prototype Business Advisory Services Private LimitedActive 12 years 7 months
Debajyoti Kumar is a mutual person
- Shib Durga Food Processing Company Private LimitedActive 14 years 11 months
Panchanan Misra is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 19 Jan 2022 | ₹4.75 M | Open |
Others Creation Date: 01 Dec 2021 | ₹2.82 M | Open |
Canara Bank Creation Date: 21 Jan 2021 | ₹1.90 Cr | Open |
How Many Employees Work at Blueray Lifesciences?
Blueray Lifesciences has a workforce of 0 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blueray Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blueray Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
